These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1018 related items for PubMed ID: 26927562

  • 21. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 22. MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.
    Sun SJ, Wang N, Sun ZW, Chen J, Cui HW.
    Eur Rev Med Pharmacol Sci; 2018 Aug 17; 22(15):4869-4878. PubMed ID: 30070322
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.
    Cao X, Xu L, Liu Q, Yang L, Li N, Li X.
    Oncol Res; 2019 Feb 21; 27(3):301-309. PubMed ID: 29562958
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 21; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 25. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.
    J Cell Mol Med; 2011 Mar 21; 15(3):691-700. PubMed ID: 20219012
    [Abstract] [Full Text] [Related]

  • 26. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY, Hu M, Zhao L, Guo WS.
    Eur Rev Med Pharmacol Sci; 2019 Jun 21; 23(12):5158-5167. PubMed ID: 31298411
    [Abstract] [Full Text] [Related]

  • 27. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
    Wang Y, Lu Z, Li Y, Ji D, Zhang P, Liu Q, Yao Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct 21; 30(10):1076-9. PubMed ID: 25270212
    [Abstract] [Full Text] [Related]

  • 28. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.
    Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408
    [Abstract] [Full Text] [Related]

  • 29. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
    Zhang Y, Zhang D, Jiang J, Dong L.
    Oncol Rep; 2017 Jan 16; 37(1):323-332. PubMed ID: 27878280
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F, Lv LZ, Cai QC, Jiang Y.
    World J Gastroenterol; 2015 Dec 21; 21(47):13268-76. PubMed ID: 26715809
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.
    FEBS J; 2015 Feb 21; 282(3):579-94. PubMed ID: 25475121
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
    Li G, Yang F, Xu H, Yue Z, Fang X, Liu J.
    Biomed Pharmacother; 2015 Jul 21; 73():154-9. PubMed ID: 26211597
    [Abstract] [Full Text] [Related]

  • 35. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
    Liu J, Wang Z, Yin Y, Li N, Ye NY, Bao B, Gu HC.
    Eur Rev Med Pharmacol Sci; 2019 May 21; 23(9):3733-3741. PubMed ID: 31114999
    [Abstract] [Full Text] [Related]

  • 36. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B, Ding F, Huang CY, Xiao H, Fei FY, Li J.
    Eur Rev Med Pharmacol Sci; 2019 Jan 21; 23(1):137-145. PubMed ID: 30657555
    [Abstract] [Full Text] [Related]

  • 37. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
    Liu CJ, Yang JH, Huang FZ, Yang JH, Liu CP, Mao XH, Yi WM, Shen XB, Peng C, Chen MF, Jiang B, Wu JS.
    Eur Rev Med Pharmacol Sci; 2018 Apr 21; 22(8):2273-2281. PubMed ID: 29762829
    [Abstract] [Full Text] [Related]

  • 38. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG, Pan YW, Feng J, Zeng CT, Zhao XQ, Liang B, Zhang WW.
    Eur Rev Med Pharmacol Sci; 2019 Mar 21; 23(5):2003-2012. PubMed ID: 30915743
    [Abstract] [Full Text] [Related]

  • 39. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y, Wang J, Han J, Luo D, Sun Z.
    Exp Cell Res; 2017 Nov 15; 360(2):210-217. PubMed ID: 28890291
    [Abstract] [Full Text] [Related]

  • 40. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y, Yan F, Wang F, Pan L.
    Tissue Cell; 2021 Oct 15; 72():101534. PubMed ID: 33991762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.